Skip to Content

Tag: weight loss drugs



Industry weighs potential impact of weight loss drugs

November 17, 2023Theresa Flaherty, Managing Editor

YARMOUTH, Maine – Respondents to a recent HME Newspoll aren’t quite sure what to make of the weight loss drug craze and whether or not it will impact demand for certain HME.  Nearly 40% of respondents say the drugs, which are known as GLP-1s and which include brand names like Ozempic and Wegovy, could reduce demand for CPAP devices, as obesity is among the most important risk factors for sleep apnea.  “Over time, I think this will have a huge impact on PAP devices...

Diabetes, Sleep Apnea, weight loss drugs

Read Full Articlered right arrow icon